课题基金 / 基金详情

Activation of ERK during ischemia-reperfusion in lung transplantation.

Activation of ERK during ischemia-reperfusion in lung transplantation.
肺移植缺血再灌注过程中 ERK 的激活。
批准号:
14571268
负责人:
SAKIYAMA Shoji
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003

项目摘要

项目成果

SAKIYAMA Shoji的其他基金

相似基金

相关文献

中文摘要
翻译
1.在大鼠肺移植模型中的实验在人肺移植的缺血再灌注过程中,发现蛋白酪氨酸磷酸化的显著变化。本研究的目的是确定这些变化是否存在于大鼠单肺移植模型。冷缺血保存6小时后进行肺移植。在同种和同种异体移植物中,移植物的肺功能保存得非常好。蛋白酪氨酸磷酸化、蛋白酪氨酸激酶和蛋白酪氨酸磷酸酶活性在再灌注2 h后显著降低。再灌注2小时后,Src蛋白水平和p38磷酸化水平降低。人肺移植中MAPK的活化本实验检测了人肺移植缺血再灌注过程中MAPK的磷酸化状态。这些移植在加拿大的多伦多综合医院进行。对15例接受移植的患者进行肺组织活检:冷缺血保存后、热缺血(植入)后和再灌注1 h或2 h后。Western blotting检测ERK、p38-MAPK、INK和MEK的磷酸化状态。在较低水平下,INK的磷酸化也显著增加。相反,p38的磷酸化没有显著变化。ERK磷酸化的增加与ERK的上游激酶MEK的激活无关。由于MKP-3蛋白水平与其活性相对应,我们检查了这些样品中MKP-3的蛋白表达。令人惊讶的是,MKP-3蛋白水平在再灌注后显著增加。因此,ERK磷酸化的显著增加不是由于MKP-3的表达受到抑制。
英文摘要
1.Experiment in a rat lung transplant model.Dramatic alterations of protein tyrosine phosphorylation have been found during the ischemia-reperfusion period of human lung transplantation. The object of the present study was to determine whether these changes exist in a rat single-lung transplant model. Lung transplantations were performed after 6 hours of cold ischemic preservation. In both iso-and allografts, the lung function of transplants was very well preserved. Protein tyrosine phosphorylation, protein tyrosine kinase and protein tyrosine phosphatase activities were decreased significantly after 2 hours of reperfusion. Src protein level and phosphorylation of p38 were reduced after 2 hours of reperfusion. This lung transplantation model is useful for studying ischemia-reperfusion injury.MAPK activation in human lung transplantThe phosphorylation status of MAPK during ischemia-reperfusion in human lung transplant was examined. These transplantations were performed in Toronto General Hospital in Canada. Lung tissue biopsy was performed on 15 patients undergoing transplantation: after the cold ischemic preservation, after the warm ischemia (implantation) and after 1 h or 2 h reperfusion. The phosphorylation status of ERK, p38-MAPK, INK and MEK was examined with Western blotting. Phosphorylation of INK also significantly increased at lower levels. In contrast, phosphorylation of p38 had no significant changes. The increase in ERK phosphotylation was not associated with the activation of MEK, the up-stream kinase for ERK. Since MKP-3 protein levels correspond to its activity, we examined the protein expression of MKP-3 in these samples. Surprisingly, the MKP-3 protein level significantly increased after reperfusion. Therefore, the dramatic increase in ERK phosphorylation is not due to the inhibited expression of MKP-3.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
Sakiyama S 他: "Ischemia-reperfusion decreases protein tyrosine phosphorylation and p38 mitogen-activated protein kinase phosphorylation in rat lung transplants"J Heart Lung Transplant. 22・3. 338-346 (2003)
Sakiyama S 等:“缺血再灌注降低大鼠肺移植中的蛋白质酪氨酸磷酸化和 p38 丝裂原激活蛋白激酶磷酸化”J Heart Lung Transplant 22・3 (2003)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Sakiyama S, dePerrot M, Han B, Waddell TK, Keshavjee S, Liu M.: "Ischemia-reperfusion decreases protein tyrosine phosphorylation and p38 mitogen-activated protein kinase phosphorylation in rat lung transplants."J Heart Lung Transplant.. 22(3). 338-346 (20
Sakiyama S、dePerrot M、Han B、Waddell TK、Keshavjee S、Liu M.:“缺血再灌注会降低大鼠肺移植中的蛋白酪氨酸磷酸化和 p38 丝裂原激活蛋白激酶磷酸化。”J Heart Lung Transplant.. 22(3
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Takehisa Y, Sakiyama S他: "Progressive increase of CD4(+)/CD45RC(-) lymphocytes after allograft rat lung transplantation : a marker of acute rejection"J Thorac Cardiovasc Surg. 124・4. 675-683 (2002)
Takehisa Y、Sakiyama S等:“同种异体移植大鼠肺移植后CD4(+)/CD45RC(-)淋巴细胞的进行性增加:急性排斥反应的标志”J Thorac Cardiovasc Surg. 124・4. )
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Takehisa Y, Sakiyama S他: "Progressive increase of CD4(+)/CD45RC(-) lymphocytes after allograft rat lung transplantation : a marker of acute rejection."J Thorac Cardiovasc Surg. 124. 675-683 (2002)
Takehisa Y、Sakiyama S 等:“同种异体大鼠肺移植后 CD4(+)/CD45RC(-) 淋巴细胞的逐渐增加:急性排斥反应的标志。”J Thorac Cardiovasc Surg. 124. 675-683 (2002)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 6 条
    Fetal lung fragments implantation into fibrotic lung of a pig model
    Experimental examination of the pulmonary emphysema treatment with fetal lung tissues transplantation - a pig emphysema model -
    • 批准号:
      23592062
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.33万
    • 财政年份:
      2011
    • 负责人:
      SAKIYAMA Shoji
    • 依托单位:
    Implantation of fetal pig lung fragments into adult rat lung parenchyma-search for a possibility of transbronchial delivery with a bronchoscope-
    • 批准号:
      20591672
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2008
    • 负责人:
      SAKIYAMA Shoji
    • 依托单位:
    IMMUNOSUPPRESSION WITH ANTI-T CELL RECEPTOR V-BETA ANTIBODY IN LUNG TRANSPLANTATON
    • 批准号:
      09671383
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.05万
    • 财政年份:
      1997
    • 负责人:
      SAKIYAMA Shoji
    • 依托单位:
    国内基金
    海外基金
    缺氧诱导因子(HIF)-2α转录抑制树突状细胞CD36表达减轻肾脏缺血再灌注损伤的机制
    • 批准号:
      82370751
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      张明
    • 依托单位:
    骨髓抑制再生单个核细胞移植通过调节线粒体功能在脑缺血再灌注损伤中的神经保护机制研究
    • 批准号:
      82371301
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      李轶
    • 依托单位:
    TRIM21蛋白促进HIF1α的降解介导耳蜗血管纹缘细胞缺血再灌注致听力损伤的机制研究
    • 批准号:
      82371142
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      刘君
    • 依托单位:
    肢体缺血后适应抑制肺泡巨噬细胞活化及防治肺缺血再灌注损伤机制的研究
    • 批准号:
      81070041
    • 项目类别:
      面上项目
    • 资助金额:
      32.0万元
    • 批准年份:
      2010
    • 负责人:
      甘辉立
    • 依托单位: